COVID-19 and protection of vaccination in patients with systemic sclerosis-associated interstitial lung disease
Description
CONCLUSION: SARS-CoV-2 vaccination is of outmost importance for every systemic sclerosis patient with interstitial lung disease. COVID-19 does not seem to promote progression of systemic sclerosis-associated interstitial lung disease in vaccinated
